Protea Biosciences Group Inc
Period Ending Dec 31, 2013 Dec 31, 2012
Total Revenue - -
Cost of Revenue - -
Gross Profit 1,223 834
Operating Expenses
Research and Development 2,773 2,845
Sales, General and Admin. 8,775 6,969
Non-Recurring Items - -
Other - -
Operating Income (10,325) (8,980)
Income From Continuing Operations
Add'l Income/Expense Items (347) (9)
Earnings Before Interest and Tax (10,672) (8,989)
Interest Expense 746 542
Earnings Before Tax (11,418) (9,531)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (11,418) (9,531)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (11,418) (9,531)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (11,418) (9,531)